Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations.

Abstract	Yoel Lubell and colleagues consider ethical and economic perspectives on mass drug administration of primaquine to limit transmission of P. falciparum malaria. Please see later in the article for the Editors' Summary.
Authors	Yoel Lubell, Lisa White, Sheila Varadan, Tom Drake, Shunmay Yeung, Phaik Yeong Cheah, Richard J Maude, Arjen Dondorp, Nicholas P J Day, Nicholas J White, Michael Parker
Journal	PLoS medicine (PLoS Med) Vol. 11 Issue 8 Pg. e1001704 (Aug 2014) ISSN: 1549-1676 [Electronic] United States
PMID	25137246 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Antimalarials Primaquine
Topics	Antimalarials (adverse effects, economics, therapeutic use) Drug Therapy (economics, ethics) Glucosephosphate Dehydrogenase Deficiency (diagnosis, epidemiology) Humans Malaria, Falciparum (economics, prevention & control, transmission) Plasmodium falciparum Primaquine (adverse effects, economics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!